Calmark Sweden AB announces that an exclusive distributor agreement has been signed with the company Savas Medikal Inc. regarding Calmark's bilirubin test for newborns. Savas Medikal was founded in 1993 and is a well-established and successful family business with a large market share and longstanding experience in the medical devices segment. The company is headquartered in Istanbul with an extensive distributor network that comprises four branches and more than 40 distributors throughout Turkey.

Savas Medikal is a market leader in POC testing, mainly in the fields of cardiology, intensive care, respiratory diagnostics and biochemistry, and offers a range of innovative products for neonatal care. In Turkey, 1.2 million children are born every year. The CE marking is valid in the country, but all medtech products must be registered with the country's "Device Tracking System", which, in Calmark's assessment, may take 1-2 months from the submission.